NCT04442581 2023-04-05Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver CancerUniversity of WashingtonPhase 2 Terminated2 enrolled 12 charts
NCT00872014 2016-04-04A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular CancerAmgenPhase 2 Completed60 enrolled